164 related articles for article (PubMed ID: 24403309)
21. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.
Truong HH; Xiong J; Ghotra VP; Nirmala E; Haazen L; Le Dévédec SE; Balcioğlu HE; He S; Snaar-Jagalska BE; Vreugdenhil E; Meerman JH; van de Water B; Danen EH
Sci Signal; 2014 Feb; 7(312):ra15. PubMed ID: 24518294
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of the expression of beta1,4-galactosyltransferase V promotes integrin beta1 maturation.
Chen X; Jiang J; Yang J; Chen C; Sun M; Wei Y; Guang X; Gu J
Biochem Biophys Res Commun; 2006 May; 343(3):910-6. PubMed ID: 16564504
[TBL] [Abstract][Full Text] [Related]
23. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus.
Nakayamada S; Saito K; Nakano K; Tanaka Y
Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136
[TBL] [Abstract][Full Text] [Related]
24. β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner.
Schooley AM; Andrews NM; Zhao H; Addison CL
Cancer Lett; 2012 Mar; 316(2):157-67. PubMed ID: 22099877
[TBL] [Abstract][Full Text] [Related]
25. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
26. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration.
Guo HB; Lee I; Kamar M; Akiyama SK; Pierce M
Cancer Res; 2002 Dec; 62(23):6837-45. PubMed ID: 12460896
[TBL] [Abstract][Full Text] [Related]
27. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
[TBL] [Abstract][Full Text] [Related]
28. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
[TBL] [Abstract][Full Text] [Related]
29. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
31. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte colony-stimulating receptor promotes beta1-integrin-mediated adhesion and invasion of bladder cancer cells.
Chakraborty A; White SM; Guha S
Urology; 2006 Jul; 68(1):208-13. PubMed ID: 16844458
[TBL] [Abstract][Full Text] [Related]
33. TRIB1 promotes colorectal cancer cell migration and invasion through activation MMP-2 via FAK/Src and ERK pathways.
Wang Y; Wu N; Pang B; Tong D; Sun D; Sun H; Zhang C; Sun W; Meng X; Bai J; Chen F; Geng J; Fu S; Jin Y
Oncotarget; 2017 Jul; 8(29):47931-47942. PubMed ID: 28624785
[TBL] [Abstract][Full Text] [Related]
34. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
[TBL] [Abstract][Full Text] [Related]
35. Cell-surface GRP78 facilitates colorectal cancer cell migration and invasion.
Li Z; Zhang L; Zhao Y; Li H; Xiao H; Fu R; Zhao C; Wu H; Li Z
Int J Biochem Cell Biol; 2013 May; 45(5):987-94. PubMed ID: 23485528
[TBL] [Abstract][Full Text] [Related]
36. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
37. Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice.
Wei H; Naruse C; Takakura D; Sugihara K; Pan X; Ikeda A; Kawasaki N; Asano M
Front Immunol; 2023; 14():1272537. PubMed ID: 37901252
[TBL] [Abstract][Full Text] [Related]
38. Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway.
Wu H; Jing X; Cheng X; He Y; Hu L; Wu H; Ye F; Zhao R
Oncotarget; 2016 Nov; 7(45):73402-73413. PubMed ID: 27705916
[TBL] [Abstract][Full Text] [Related]
39. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.
Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B
Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
